SOPHARMA AD: Sopharma monthly jan 2012

opublikowano: 2012-02-02 13:15

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Sopharma_monthly_jan_2012.docx  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 12 / 2012
Date of issue: 2012-02-02
Short name of the issuer
SOPHARMA AD
Subject
Sopharma monthly jan 2012
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:



Dear Sir or Madam,
In compliance with the provisions of art. 100k., para 1 from the POSA, we would like to notify that for the month of January 2012 due to the bad weather conditions Sopharma AD realized decrease in sales revenues on annual basis of 17%, including 37% for the domestic market, 9% for the export markets.
In accordance with the provisions of art. 100 k., para. 1 from the POSA, please make the aforementioned information public.

02.02.2012 Pelagia Viatcheva
/IR Director, Sopharma AD/
Annexes
File Description
Sopharma monthly jan 2012.docx Sopharma monthly jan 2012.docx Sopharma monthly jan 2012

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-02-02 Ognian Donev Executive Director